Stuttering clinical trials at UCSF

1 research study open to eligible people

Stuttering is a speech disorder that makes it hard to speak smoothly. UCSF is measuring how a dopamine medication affects speech and brain signals in adults who stutter. Researchers record speech tasks and brain activity during the test.

Showing trials for

  • Dopamine and Sensorimotor Function in Stuttering

    open to eligible people ages 18-65

    This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.

    San Francisco, California

Our lead scientists for Stuttering research studies include .

Last updated: